Akums Drugs & Pharmaceuticals Limited, headquartered in Delhi, India, is the country’s largest contract development and manufacturing organization (CDMO), specializing in pharmaceutical formulations, active pharmaceutical ingredients (APIs), and branded generic medicines. With cutting-edge manufacturing facilities, regulatory compliance, and innovation-driven R&D, Akums has positioned itself as a .
global leader in pharmaceutical contract manufacturing
Core Business & Specialization
Akums Drugs & Pharmaceuticals is a fully integrated CDMO, offering end-to-end pharmaceutical manufacturing solutions, including:
Formulation development
API manufacturing
Branded generics production
Regulatory support
Technology transfer & licensing
Quality assurance and compliance
The company caters to leading pharmaceutical brands worldwide, providing customized drug formulations and private-label manufacturing.
Product Portfolio
1. Pharmaceutical Formulations
Akums manufactures over 12,000+ drug formulations, covering various dosage forms, including:
Tablets – Immediate release, controlled release, chewable, and effervescent tablets.
Capsules – Hard gelatin and enteric-coated capsules.
Soft Gelatin Capsules – Nutraceutical and pharmaceutical-grade soft gels.
Liquid Orals – Syrups, suspensions, and solutions.
Sachets – Single-dose granule formulations.
Vials & Ampoules – Injectable medications in sterile packaging.
Topical Preparations – Creams, ointments, gels, and lotions.
USFDA & EU-GMP Approvals – Authorized for exports to the United States and European Union.
TGA (Australia), ANVISA (Brazil), and Health Canada Approvals – Meeting international regulatory guidelines.
ISO 9001:2015 Certified – Quality management system compliance.
FSSAI Approved – Regulatory compliance for nutraceutical and food-grade formulations.
Global Market Presence & Strategic Partnerships
Akums serves more than 1,500 pharmaceutical companies across 50+ countries, including:
India
United States
Europe
Latin America
Middle East & Africa
Southeast Asia
The company has long-term partnerships with leading multinational pharmaceutical companies and has contributed to the launch of multiple blockbuster generic and nutraceutical products globally.
Financial Growth & Business Performance
Akums has shown strong financial growth and expansion, driven by contract manufacturing demand and API exports.
Annual revenue exceeding $1.2 billion.
15-20% year-on-year growth in contract manufacturing operations.
Investment in new biologics and biosimilars manufacturing capabilities.
Expansion into complex generics and oncology drug formulations.
Industry Recognition & Competitive Edge
Akums has received multiple awards for its excellence in pharmaceutical manufacturing and R&D innovation.
“Best Contract Manufacturing Organization” at CPhI Awards.
Recognized as India's largest third-party pharmaceutical manufacturer.
Winner of multiple “Excellence in Quality” awards by pharma industry associations.
Patented and proprietary drug delivery innovations in sustained release and fast-acting formulations.
Future Growth & Expansion Plans
Akums is investing heavily in biopharmaceuticals, high-potency drugs, and novel drug delivery technologies. Key focus areas for expansion include:
Expansion into oncology, biosimilars, and personalized medicine.
Increased production capacity for sterile injectables and biologics.
Acquisition of advanced R&D capabilities for new drug formulations.
Strengthening global distribution channels and exports.
Conclusion
With its strong commitment to quality, innovation, and regulatory compliance, Akums Drugs & Pharmaceuticals Limited is a leading force in the global pharmaceutical manufacturing industry. The company’s state-of-the-art facilities, diverse product portfolio, and strategic partnerships position it as a trusted CDMO for major pharmaceutical brands worldwide.
